Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
DUBLIN, Ireland and TREVOSE, Pa., Dec. 7, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP) today announced that the United States Patent and Trademark Office (USPTO) issued a patent...
-
DUBLIN, Ireland and TREVOSE, Pa., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) today announced that management will be presenting at the 26th Annual Oppenheimer Healthcare...
-
DUBLIN, Ireland and TREVOSE, Pa., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) today announced that management will be presenting at the Arctic Biotech Seminar in Oslo,...
-
Strongbridge Advances Clinical Development of Rare Endocrine Disease Portfolio With COR-003, COR-004 and COR-005 Strongbridge Expands Key Functional Area Expertise With Senior Hires Strongbridge...
-
DUBLIN, Ireland and TREVOSE, Pa., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) today announced that management will be presenting at the Stifel 2015 Healthcare Conference...
-
DUBLIN, Ireland and TREVOSE, Pa., Nov. 3, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) today announced that results from a secondary efficacy analysis of the completed Phase 2...
-
DUBLIN, Ireland and TREVOSE, Pa., Oct. 21, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) announced today the closing of its initial U.S. public offering of 2,500,000 ordinary...
-
DUBLIN, Ireland and TREVOSE, Pa., Oct. 16, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP) announced today the pricing of its initial U.S. public offering of 2,500,000 ordinary...